CD4+ T Lymphocytes May Contribute to Diabetes in Women With HIV
In women with HIV and diabetes mellitus, CD4+ lymphocytes may contribute to the development of diabetes mellitus.
Diabetes
SGLT-2 Inhibitor Use Not Linked to Increased Risk for UTI Events
Initiation of therapy with SGLT-2 inhibitors for T2D mellitus is not associated with an increased risk for UTI events compared with initiation of other second-line antidiabetic medications.
Pathogens, Drug Resistance in People With Diabetes, Acute Cerebral Infarction and Pulmonary Infection
Multidrug-resistant gram-negative bacilli were the pathogens commonly found in patients with acute cerebral infarction complicated by diabetes mellitus and nosocomial pulmonary infection.
Diabetes and BMI Associated With Newly Diagnosed Active Tuberculosis
An association has been identified between newly diagnosed active tuberculosis, diabetes, and body mass index.
Factors Linked to Pneumococcal Vaccination Status in Type 2 Diabetes
Patients with diabetes are at higher risk for hospitalization and mortality because of pneumococcal infection; however, uptake of vaccination remains suboptimal.
Increased Risk for Type 2 Diabetes in People With HIV and Lipodystrophy
People living with HIV, non-alcoholic fatty liver disease, and antiretroviral-associated lipodystrophy may be at an increased risk of developing type 2 diabetes.
Insulin Resistance in Adults Infected With HIV
Insulin resistance has been identified as a key driver of CVD and other complications in people living with HIV.
Direct-Acting Agents for Hepatitis C Reduce Risk for Incident Diabetes
In a large cohort of patients with HCV, the use of DAA was associated with significantly lower incidence and risk for subsequent diabetes.
Significant Risk for Severe TB and CVD in Patients With Comorbid TB/Diabetes
The majority of cases of diabetes in patients with tuberculosis are diagnosed, but are poorly controlled in 4 TB-endemic countries.
INF Treatment Lowers Risk for Diabetes and Mortality in HIV/HCV Coinfection
Sustained virologic response to the HCV in patients with HCV and HIV coinfection is associated with a lowered risk of diabetes and mortality.
Next post in HIV/AIDS
